10-K Decoder · All companies

Cytek Biosciences, Inc.

CTKB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$201M$200M+0.5%
Operating income−$40.4M−$20.5M−96.8%
Net income−$66.5M−$6.02M−1,005%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$53.2M$52.3M+1.7%
Operating income−$8.40M−$9.20M+8.7%
Net income−$6.10M−$5.50M−10.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Cytek Biosciences's revenue in FY2025?
$201M in FY2025 (Fiscal year ended Dec 31, 2025), +0.5% vs $200M a year earlier, per its 10-K filed Feb 2026.
Was Cytek Biosciences profitable in FY2025?
No: net income was −$66.5M and operating income −$40.4M in FY2025.
What was Cytek Biosciences's revenue in Q3 2026?
$53.2M (+1.7% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.